compliance
-
CMS Is Getting More Serious About Penalizing Hospitals For Price Transparency Noncompliance
CMS has fined two hospitals in September for alleged violations of its price transparency rule. This marks the third month in a row that the agency has issued fines against hospitals for price transparency noncompliance, following a yearslong period of light enforcement.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Hospitals’ Price Transparency Compliance Is Improving Despite Remaining Low at 36%
About 36% of U.S. hospitals are in compliance with CMS’ price transparency rule, up from 24.5% in February, according to a new report. This progress will remain slow unless CMS can do a better job of effectively enforcing its rule, the report declared.
-
In Rare Move, CMS Fines 2 Hospitals for Price Transparency Violations
CMS recently fined two hospitals for alleged violations of its price transparency rule. These fines are only the third and fourth penalties issued by the agency since the rule took effect on January 1, 2021. These fines may become more common — CMS also announced that it is updating its enforcement process for the rule.
-
Amid Economic Uncertainty, Health Systems Prioritize ROI
By evaluating the potential of healthcare operations software investments to affect each of these three key outcomes areas — patient outcomes, workforce outcomes, and risk and compliance outcomes — CIOs can make informed decisions that drive value and improve outcomes for patients, providers, and the entire organization.
-
MedCity Influencers, Devices & Diagnostics, Legal
Top 5 Compliance Issues for Medtech Firms Transitioning To Data-enabled Solutions
Medtech companies should be particularly mindful of the following legal and regulatory compliance issues. This is especially true for companies transitioning to data-based services.
-
MedCity Influencers, Devices & Diagnostics
Top 5 FDA considerations for medtech-enabled data platforms
Medtech companies should have a team of FDA advisors at the ready to develop and implement pre- and post-market strategies, prevent and resolve pre- or post-market issues and guide lifecycle management
-
MedCity Influencers, Artificial Intelligence
The future of regulatory labeling compliance depends on technology adoption
The life sciences industry is more quickly adapting to new methods, standards and requirements. The focus is now on how to drive greater data governance and quality through a unified framework. The challenge comes in instituting a framework that will meet regulatory and labeling requirements.
-
Audits and penalties possible for noncompliance with new notification, digital contact rules
A CMS rule, which went into effect December 31, requires that providers publish up-to-date digital contact information regarding their compliance, using approved methods. Noncompliant hospitals will be publicly listed, akin to the Office of Civil Rights’ breach notification portal, the so-called “Wall of Shame.”
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Only 5% hospitals are compliant with price transparency rule. Here’s how they did it.
The hospitals that were found to be fully compliant with the federal price transparency rule had a few strategies in common, including picking the right technology partner and beginning their efforts early — in some cases before the rule was even proposed.
-
CMS proposes fining hospitals up to $2M annually for not following price transparency rule
CMS’ latest proposed rule, which includes stringent penalties for hospitals that are found to be flouting the price transparency rule, comes on the heels of an analysis showing that a vast majority of hospitals are not in compliance with the regulation that went into effect on Jan. 1.
-
Compliance with HIPAA may offer some clues on how providers will fare with new info blocking rules
Despite a 20-year head start, providers still fall short of HIPAA requirements around fulfilling patient requests for their medical records. In light of the federal information blocking rules, providers should first examine their compliance with HIPAA and then address the new demands imposed by the recently enacted regulations.
-
Analysis: Most hospitals not complying with price transparency rule
The federal price transparency rule for hospitals went into effect Jan. 1, but a new analysis shows that a majority of providers studied were “unambiguously noncompliant.”
-
4 signs your compliance program is out of date
Many players in life sciences and other sectors balk at updating their compliance systems because of the cost and resources involved, but addressing possible lapses now can save your company millions of dollars in fines and reputational damage.
-
Hospitals, Telemedicine, Physicians
What providers need to know about OIG’s plans to audit telehealth services
The Office of the Inspector General will audit Medicare Part B telehealth services to detect potential vulnerabilities and ensure compliance with regulatory requirements. To prepare, providers must first take stock of their programs and conduct audits of their own, experts say.